Physician profile
Andrew Phillip Alvarez
NPI 1699164376
$28,581.29
in general payments reported to CMS, 2019-2025
39 companies · $6,562 in 2025
The $6,562 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $664 · 2022: $7,394 · 2023: $4,118 · 2024: $9,842 · 2025: $6,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $8,592 · Education: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,023.67 |
| Food and Beverage | $8,591.95 |
| Education | $906.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $10,284.54 | 2023-2025 | Other - Miscellaneous |
| Stryker Corporation | $5,615.83 | 2022-2025 | Monterey Al, Everest Spinal System, Serrato |
| Cerapedics INC. | $3,578.05 | 2021-2022 | |
| Vb Spine LLC | $3,309.44 | 2025 | Tritanium Pl, Monterey Al, Canyon Retractor Systems |
| Medtronic, INC. | $2,902.55 | 2021-2023 | Cd Horizon Spinal System, Mazor X System |
| Centinel Spine, LLC | $429.47 | 2023 | Prodisc C Vivo |
| Next Science LLC | $376.30 | 2022-2025 | Xperience, Blastx, Surgx |
| Depuy Synthes Sales INC. | $328.34 | 2022-2023 | Expedium Verse, Symphony, Expedium |
| Boston Scientific Corporation | $230.87 | 2024-2025 | Intracept, Watchman Flx |
| Nuvasive, INC. | $161.76 | 2022 | |
| Reel Surgical, INC. | $152.09 | 2023-2024 | |
| Corelink, LLC | $120.03 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $113.58 | 2023-2025 | Exparel, Zilretta |
| Mimedx Group, INC. | $100.93 | 2024-2025 | |
| Integra Lifesciences Corporation | $77.71 | 2023 | Tenoglide |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $70.99 | 2022-2025 | Actastim-S |
| Zimvie INC. | $62.81 | 2023-2024 | |
| Augmedics INC. | $56.92 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $54.46 | 2025 | |
| Smith+Nephew, INC. | $51.79 | 2023-2024 | Pico 14 |
| Nanovis LLC | $50.56 | 2023 | |
| Orthofix Medical, INC. | $49.40 | 2022-2023 | Spinal-Stim, Spinal-Stim |
| Bioventus LLC | $37.53 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Sanara Medtech INC. | $34.80 | 2022-2025 | Celleraterx |
| Ferring Pharmaceuticals INC. | $34.24 | 2023 | Euflexxa |
| Arthrex, INC. | $34.00 | 2024 | |
| Providence Medical Technology, INC. | $28.06 | 2025 | |
| Heron Therapeutics, INC. | $26.50 | 2025 | Zynrelef |
| Abbott Laboratories | $24.64 | 2025 | Eterna |
| Ossdsign USA Incorporated | $24.00 | 2024 | |
| Convatec INC. | $22.70 | 2024 | |
| Ethicon US, LLC | $22.10 | 2023 | Stratafix |
| Averitas Pharma INC. | $19.49 | 2023 | Qutenza |
| Endo Pharmaceuticals INC. | $17.89 | 2023 | Xiaflex |
| Amgen INC. | $17.86 | 2024 | |
| Guard Medical INC. | $16.97 | 2025 | Npseal |
| Curonix LLC | $16.56 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Supernus Pharmaceuticals, INC. | $14.07 | 2024 | Qelbree |
| Si-Bone, INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.